Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2000
08/08/2000CA2176678C Test sample card
08/08/2000CA2017793C Method and apparatus for determining low temperature performance of a wax containing fuel
08/08/2000CA2014318C Reagents, methods and kits for an amphetamine-class fluorescence polarization immunoassay
08/08/2000CA2002620C Fingerprint reagent
08/08/2000CA2002218C Neoglycoproteins, the preparation and use thereof
08/08/2000CA1341082C Method of treating tumor cells by inhibiting growth factor receptor function
08/08/2000CA1341076C Methods and devices for conducting assays
08/03/2000WO2000045354A1 Fire detection method
08/03/2000WO2000045334A1 Protein modeling tools
08/03/2000WO2000045322A1 Determining protein function and interaction from genome analysis
08/03/2000WO2000045179A2 Screening for modulators of g-protein subunit beta 3
08/03/2000WO2000045178A1 Method of evaluating myelosuppressive state
08/03/2000WO2000045177A1 Assays for modulators of elongation factor p activity
08/03/2000WO2000045176A2 METHOD OF IDENTIFYING N-TERMINAL proBNP
08/03/2000WO2000045175A1 Urinary trypsin inhibitor to diagnose aids
08/03/2000WO2000045174A1 Whole cell selection utilizing azlactone-functional supports
08/03/2000WO2000045173A1 Inhibitors of intimin adhesion and tests for their screening
08/03/2000WO2000045171A1 Immunoassays using casein coating of particles
08/03/2000WO2000045170A2 Method and apparatus for detecting molecular binding events
08/03/2000WO2000045169A1 Methods for enhancing binding interactions between members of specific binding pairs
08/03/2000WO2000045168A1 Method and kit for identifying or characterising polypeptides
08/03/2000WO2000045167A2 Non-invasive method for detecting target rna
08/03/2000WO2000045166A1 Measurement of lesion progression via mapping of chromatin texture features along progression curve
08/03/2000WO2000045165A1 Methods of identifying therapeutically effective antineoplastic agents with cultured cells having intact cell membranes and corresponding products
08/03/2000WO2000045163A2 Microsensor housing
08/03/2000WO2000045162A1 Blood coagulation preventing agents and blood collection containers containing the same
08/03/2000WO2000045160A1 Method and apparatus for detecting molecular binding events
08/03/2000WO2000045157A1 Method and arrangement for determining the moisture content of wood chips
08/03/2000WO2000045156A1 Method for monitoring quality of paper web
08/03/2000WO2000045145A2 Method and device for measuring insulating fluids
08/03/2000WO2000045133A1 Measuring multiphase flow in a pipe
08/03/2000WO2000044939A1 Replicable probe array
08/03/2000WO2000044935A2 Multiplex real-time pcr
08/03/2000WO2000044932A2 Homogeneous enzymatic assay for vitamin b6
08/03/2000WO2000044930A1 Diagnostic test for the measurement of analyte in a biological fluid
08/03/2000WO2000044929A2 Assays for sensory modulators using a sensory cell specific g-protein alpha subunit
08/03/2000WO2000044913A1 Metalloprotease polynucleotides and polypeptides
08/03/2000WO2000044906A2 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI)
08/03/2000WO2000044904A1 Basb059 polypeptides from neisseria meningitidis
08/03/2000WO2000044903A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
08/03/2000WO2000044900A2 Nucleic-acid binding proteins
08/03/2000WO2000044897A1 Method of treating restenosis by antisense targeting of c-myc
08/03/2000WO2000044894A1 Method for isolating apoptosis-inducing dna sequences and detection system
08/03/2000WO2000044888A2 Dimethylarginine dimethylaminohydrolases
08/03/2000WO2000044884A1 Bhv-1 gene-deleted virus vaccine
08/03/2000WO2000044879A1 Aggressive prostate cancer sublines selected by androgen deprivation
08/03/2000WO2000044876A2 Method, vessel and device for monitoring metabolic activity of cell cultures in liquid media
08/03/2000WO2000044790A1 Anti-ccr1 antibodies and methods of use therefor
08/03/2000WO2000044775A2 Identification of broadly reactive hla restricted t cell epitopes
08/03/2000WO2000044774A2 Inhibition of stat3 signal transduction for human cancer therapy
08/03/2000WO2000044772A2 Human serum albumin
08/03/2000WO2000044407A2 Materials and methods to inhibit hodgkin and reed sternberg cell growth
08/03/2000WO2000044403A1 Her-2 binding antagonists
08/03/2000WO2000044395A1 Methods and compositions for modulating fertility
08/03/2000WO2000044392A2 Identification of specific differentially expressed mycobacterial antigens
08/03/2000WO2000044281A1 Apparatus and method for detecting anomalies in human tissue
08/03/2000WO2000044273A2 Diagnosis and prediction of light therapy response in seasonal affect disorder patients using g-protein subunit measurements
08/03/2000WO2000027999A3 Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices
08/03/2000WO2000027874A3 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
08/03/2000WO2000026238A3 Biological materials and methods useful in the diagnosis and treatment of prion diseases
08/03/2000WO2000023785A3 Improvements in luminescence assays
08/03/2000WO2000020835A3 Thromboplastin reagents and methods for preparing and using such reagents
08/03/2000WO2000012760A3 Toxicological response markers
08/03/2000WO2000009996A9 Improving radio frequency spectral analysis for in-vitro or in-vivo environments
08/03/2000WO2000009691A9 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
08/03/2000WO2000009689A9 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof
08/03/2000WO2000009669A9 Human mesencephalon cell lines and methods of use therefor
08/03/2000WO2000009550A9 Vanadate resistance glycosylation 4 gene
08/03/2000WO2000009549A9 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
08/03/2000WO2000009076A9 Imaging with tc-99m labeled fibrin-alpha-chain peptide
08/03/2000WO2000009074A9 Variable output applicator and method for multi-component biologic fluid agents, and application method
08/03/2000WO2000008211A3 Methods and compositions for modulating 'marginally indiscriminant' hybridizations
08/03/2000WO2000006589A9 Prostate derived ets factor
08/03/2000WO1999062941A8 Serpentine transmembrane antigens expressed in human cancers and uses thereof
08/03/2000DE19900129A1 Gasqualitätsbestimmung Gas quality determination
08/03/2000DE19860169A1 Quantitative determination of small amounts of water in multilayered system in liquid state e.g. oil involves incomplete extraction of water, quantitative determination of extracted water and calculating amount of water in the system
08/03/2000DE19852928C1 Strukturen in Form von Hohlkugeln Structures in the form of hollow spheres
08/03/2000DE10004049A1 Verfahren zum Prüfen von Gegenständen aus Kunststoff A method for testing of objects made of plastic
08/03/2000CA2363565A1 Basb059 polypeptides from neisseria meningitidis
08/03/2000CA2361621A1 Inhibition of stat3 signal transduction for human cancer therapy
08/03/2000CA2361271A1 Methods and compositions for modulating fertility
08/03/2000CA2361246A1 Identification of specific differentially expressed antigens
08/03/2000CA2361163A1 Replicable probe array
08/03/2000CA2361119A1 Method, vessel and device for monitoring metabolic activity of cell cultures in liquid media
08/03/2000CA2360997A1 Non-invasive method for detecting target rna
08/03/2000CA2360725A1 Apparatus and method for detecting anomalies in human tissue
08/03/2000CA2360085A1 Genes identified as required for proliferation in escherichia coli
08/03/2000CA2360019A1 Anti-ccr1 antibodies and methods of use therefor
08/03/2000CA2359898A1 Determining protein function and interaction from genome analysis
08/03/2000CA2359889A1 Protein modeling tools
08/03/2000CA2359701A1 Nucleic-acid binding proteins
08/03/2000CA2359664A1 Methods for enhancing binding interactions between members of specific binding pairs
08/03/2000CA2359321A1 Diagnostic test for the measurement of analyte in a biological fluid
08/03/2000CA2359317A1 Method of treating restenosis by antisense targeting of c-myc
08/03/2000CA2359316A1 Method and arrangement for determining the moisture content of wood chips
08/03/2000CA2359315A1 Method for monitoring quality of paper web
08/03/2000CA2359230A1 Method and device for measuring the acidity or basicity of insulating fluids, particularly mineral and synthetic oils
08/03/2000CA2354184A1 Multiplex real-time pcr
08/02/2000EP1024364A1 Methods of diagnosing or prognosing Alzheimer's disease
08/02/2000EP1024363A2 Quantitative determination of analytes in a heterogeneous system